Serevent and Lung neoplasm malignant - a phase IV clinical study of FDA data

Summary:

Lung neoplasm malignant is reported as a side effect among people who take Serevent (salmeterol xinafoate), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Xanax, and have Bone density abnormal.

The phase IV clinical study analyzes which people have Lung neoplasm malignant when taking Serevent. It is created by eHealthMe based on reports of 15,422 people who have side effects when taking Serevent from the FDA, and is updated regularly.

What is Serevent?

Serevent has active ingredients of salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 15,586 Serevent users. Check the latest studies of Serevent.

What is Lung neoplasm malignant?

Lung neoplasm malignant (cancer tumour of lung) is found to be associated with 1,149 drugs and 928 conditions by eHealthMe. Check the latest studies of Lung neoplasm malignant.

On Aug, 05, 2026

15,422 people reported to have side effects when taking Serevent.
Among them, 38 people (0.25%) have Lung neoplasm malignant.

Could Serevent cause Lung neoplasm malignant?

Among these 38 people:

How long have people been on Serevent when they have Lung neoplasm malignant? *

What is the gender of people who have Lung neoplasm malignant when taking Serevent? *

female: 65.79 %
male: 34.21 %

What is the age of people who have Lung neoplasm malignant when taking Serevent? *

What are other drugs people take besides Serevent? *

What are other side effects people have besides Lung neoplasm malignant? *

Cough: 14 people, 36.84%
Chest Pain: 14 people, 36.84%
Stress And Anxiety: 14 people, 36.84%
Insomnia (sleeplessness): 13 people, 34.21%
Cervical Spinal Stenosis (narrowing of the spinal canal in the neck): 13 people, 34.21%
Cerebrovascular Disorder (disease of brain): 13 people, 34.21%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 13 people, 34.21%
Injury: 13 people, 34.21%
Injury Corneal: 13 people, 34.21%
Bronchopleural Fistula: 13 people, 34.21%

What are the existing conditions these people have? *

Bone Density Abnormal: 11 people, 28.95%
Osteoporosis (bones weak and more likely to break): 5 people, 13.16%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 4 people, 10.53%
Insomnia (sleeplessness): 3 people, 7.89%
Urination - Painful: 1 person, 2.63%
Hepatitis C: 1 person, 2.63%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 2.63%
Back Pain: 1 person, 2.63%
Blood Glucose Abnormal: 1 person, 2.63%
Cardiac Disorder: 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Serevent and have Lung neoplasm malignant?

- Check whether Lung neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Serevent:

Serevent (15,586 reports)

Browse all side effects of Serevent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lung neoplasm malignant:

Lung neoplasm malignant (1,149 drugs)

Browse all the conditions that are associated with Lung neoplasm malignant:

Lung neoplasm malignant (928 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on salmeterol xinafoate (the active ingredients of Serevent) and Serevent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.